KRISTA GESSLER: Open Payments
NPI 1013455310 · SMYRNA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,147 in 131 payments from 14 companies in 2025. Trend: 2023 $926 · 2024 $1,432 · 2025 $2,147
Food & beverage: $2,113Education: $34
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 34 | $514 |
| AstraZeneca Pharmaceuticals LP | 12 | $359 |
| Grifols USA, LLC | 18 | $196 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $184 |
| GENZYME CORPORATION | 11 | $172 |
| Viatris Specialty LLC | 14 | $161 |
| Verona Pharma, Inc. | 8 | $153 |
| Amgen Inc. | 12 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $80 |
| Insmed, Inc. | 3 | $68 |
Products named: NUCALA, TEZSPIRE, Prolastin-C Liquid, TRELEGY ELLIPTA, DUPIXENT, YUPELRI, Ohtuvayre, OFEV.
Industry payments across TN — which companies pay providers there.
